Key Points
- Anthem director Robin Shane Readnour sold 6,100 shares at an average price of $6.07, generating $37,027 and reducing their holdings by 1.07% to 562,715 shares. The director also reported additional sales of 10,019 shares on September 8 and 35,402 shares on August 17.
- Anthem shares were trading at $5.98, up 1.5%, with a market capitalization of approximately $225.7 million. The company reported a quarterly loss of $0.18 per share.
- Analyst sentiment is mixed, with two Buy ratings and one Sell rating producing a consensus Hold rating and an average price target of $9.00; institutional investors own 90.47% of the stock.
-logo-1200x675.jpg?v=20220419083428)
Anthem, Inc. (NASDAQ:ANTX - Get Free Report) Director Robin Shane Readnour sold 6,100 shares of the business's stock in a transaction on Thursday, September 3rd. The shares were sold at an average price of $6.07, for a total transaction of $37,027.00. Following the completion of the transaction, the director directly owned 562,715 shares of the company's stock, valued at $3,415,680.05. This trade represents a 1.07% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Robin Shane Readnour also recently made the following trade(s):
- On Tuesday, September 8th, Robin Shane Readnour sold 10,019 shares of Anthem stock. The stock was sold at an average price of $6.02, for a total value of $60,314.38.
- On Monday, August 17th, Robin Shane Readnour sold 35,402 shares of Anthem stock. The stock was sold at an average price of $6.01, for a total value of $212,766.02.
Anthem Trading Up 1.5%
NASDAQ:ANTX opened at $5.98 on Wednesday. Anthem, Inc. has a 1 year low of $1.00 and a 1 year high of $7.19. The stock has a 50-day moving average price of $5.33 and a two-hundred day moving average price of $4.41. The stock has a market cap of $225.66 million, a price-to-earnings ratio of -5.59 and a beta of -0.99.
Anthem (NASDAQ:ANTX - Get Free Report) last released its quarterly earnings results on Tuesday, August 11th. The company reported ($0.18) EPS for the quarter.
Wall Street Analysts Forecast Growth
Several research analysts have recently weighed in on ANTX shares. Leerink Partners upgraded shares of Anthem from a "market perform" rating to an "outperform" rating and set a $9.00 price target for the company in a report on Thursday, May 14th. Guggenheim initiated coverage on Anthem in a research note on Monday, July 20th. They issued a "buy" rating and a $9.00 price target on the stock. Weiss Ratings restated a "sell (d-)" rating on shares of Anthem in a research note on Monday, July 6th. Finally, Wall Street Zen raised shares of Anthem from a "sell" rating to a "hold" rating in a research note on Sunday, June 14th. Two analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $9.00.
Check Out Our Latest Stock Report on Anthem
Institutional Trading of Anthem
Institutional investors and hedge funds have recently bought and sold shares of the business. Spruce Street Capital LP acquired a new stake in Anthem during the 1st quarter valued at $5,576,000. OMERS ADMINISTRATION Corp acquired a new position in shares of Anthem in the first quarter valued at $54,000. Commodore Capital LP acquired a new position in shares of Anthem in the first quarter valued at $7,981,000. ADAR1 Capital Management LLC bought a new position in shares of Anthem in the first quarter valued at about $47,000. Finally, Ally Bridge Group NY LLC bought a new position in shares of Anthem in the first quarter valued at about $1,800,000. Institutional investors own 90.47% of the company's stock.
Anthem Company Profile
(
Get Free Report)
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
